Differences in Patient-Reported Outcome Measures in Patients With Cancer Six Months Before Death All premenopausal patients who underwent first HSCT from June 2016 to January 2022 were included in ...

The original results of this study were first reported in 1993. [1] At that time, with limited follow-up, no survival difference was found between patients in the autologous or allogeneic groups.

This large and ambitious review and meta-analysis investigated reports going as far back as the 1990s. Although the investigators concluded that blood transfusion is the driving force leading to ...

ROCHESTER, Minn. – A growing number of hospitals have implemented patient blood management programs to reduce unnecessary blood transfusions and costs. A study published in Mayo Clinic Proceedings ...

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell transplantation (HSCT) remains the only widely accessible curative option for this ...

ANN ARBOR, Mich. -- Blood transfusions save the lives of millions of heart surgery patients and others each year. But a new study suggests that patients who receive transfusions during heart bypass ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid utilization did not increase the risk for thrombotic events in high-risk patients. Tranexamic ...

Early intraoperative normovolemic hemodilution failed to save red blood cell supplies in a randomized clinical trial of over 2,000 people. The single-blind trial had people undergoing cardiac surgery ...